{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T01:17:01Z","timestamp":1785028621208,"version":"3.55.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T00:00:00Z","timestamp":1718668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T00:00:00Z","timestamp":1718668800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>\n                      Cutaneous Leishmaniasis (CL) is caused by protozoan parasite called\n                      <jats:italic>Leishmania<\/jats:italic>\n                      . It is endemic in more than 100 countries globally. Despite its vast prevalence and impact on quality of life, it is one of the most neglected tropical dermatological diseases. The CL burden has often been expressed based on the physical disfigurement caused by the disease. However, considering the impact of the disease beyond physical impairment and changes in patients\u2019 appearance would help to better understand the disease as a public health problem. The effect of CL on patients\u2019 quality of life was determined in this study.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      The data that were related to quality of life were collected using Standard one-week Dermatology Life Quality Index (DLQI) questionnaire. The questions were categorized under seven domains: symptoms &amp; feelings, daily activities, work and school, leisure, personal relationships, and treatment. Each question was scored on a three-point scale: Very much (3), A lot (2), A little (1), Undecided (0), and Not at all (0). The sum of the scores lied between 0 and 48. A higher score shows worse quality of life. The data were entered and analysed using Statistical Package for Social Science 23. Frequencies and proportions were used to describe the data. Differences were considered statistically significant at\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The lives of the majority of CL patients (60.7%) were significantly affected by CL. The quality of life of patients was moderately impacted by CL in 25% of the CL patients. In 32.1% of the CL patients, the effect of CL on patients\u2019 quality of life was very large. The quality of one CL patient\u2019s life was extremely largely affected. The disease had a small effect on 32.1% of the CL patients. Personal relationship was the most affected domain followed by symptoms and feelings and treatment. Future study including rural regions is required.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The Dermatology Life Quality Index demonstrates that CL has a small to extremely very large negative effect on the quality of life of patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-024-09518-3","type":"journal-article","created":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T17:01:44Z","timestamp":1718730104000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Effects of cutaneous leishmaniasis on patients\u2019 quality of life"],"prefix":"10.1186","volume":"24","author":[{"given":"Endalew","family":"Yizengaw","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Endalkachew","family":"Nibret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,18]]},"reference":[{"key":"9518_CR1","first-page":"165","volume":"25","author":"JA Ruiz-Postigo","year":"2020","unstructured":"Ruiz-Postigo JA, Grout L, Jain S. Global leishmaniasis surveillance, 2017\u20132018, and first report on 5 additional indicators weekly. Epidemiol Record. 2020;25:165\u2013280.","journal-title":"Epidemiol Record"},{"key":"9518_CR2","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1186\/1756-3305-5-276","volume":"5","author":"A Dostalova","year":"2012","unstructured":"Dostalova A, Volf P. Leishmania development in sand flies: parasite-vector interactions overview. Parasit Vectors. 2012;5:276.","journal-title":"Parasit Vectors"},{"issue":"1","key":"9518_CR3","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s13071-017-2028-5","volume":"10","author":"D Steverding","year":"2017","unstructured":"Steverding D. The history of leishmaniasis. Parasit Vectors. 2017;10(1):82.","journal-title":"Parasit Vectors"},{"key":"9518_CR4","unstructured":"Guideline for Diagnosis. Treatment and Prevention of Leishmaniasis in Ethiopia 2013."},{"issue":"11","key":"9518_CR5","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1111\/ijd.16265","volume":"61","author":"EY Shita","year":"2022","unstructured":"Shita EY, Nibret E, Munshea A, Gashaw B. Burden and risk factors of cutaneous leishmaniasis in Ethiopia: a systematic review and meta-analysis. Int J Dermatol. 2022;61(11):1336\u201345.","journal-title":"Int J Dermatol"},{"key":"9518_CR6","doi-asserted-by":"crossref","unstructured":"Endalew Yizengaw EN, Gizachew Yismaw B, Gashaw D, Tamiru A, Munshea, Yegnasew Takele IM, Lloyd Chapman R, Weller JA, Cotton. Pascale Kropf. Cutaneous leishmaniasis in a newly established treatment centre in the Lay Gayint district, Northwest Ethiopia. Skin Health Disease. 2023:1\u20138.","DOI":"10.1002\/ski2.229"},{"issue":"1","key":"9518_CR7","doi-asserted-by":"publisher","first-page":"106","DOI":"10.3855\/jidc.8516","volume":"11","author":"F Dassoni","year":"2017","unstructured":"Dassoni F, Daba F, Naafs B, Morrone A. Leishmaniasis recidivans in Ethiopia: cutaneous and mucocutaneous features. J Infect Dev Ctries. 2017;11(1):106\u201310.","journal-title":"J Infect Dev Ctries"},{"key":"9518_CR8","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1186\/1756-3305-5-240","volume":"5","author":"K Deribe","year":"2012","unstructured":"Deribe K, Meribo K, Gebre T, Hailu A, Ali A, Aseffa A, Davey G. The burden of neglected tropical diseases in Ethiopia, and opportunities for integrated control and elimination. Parasit Vectors. 2012;5:240.","journal-title":"Parasit Vectors"},{"issue":"10","key":"9518_CR9","doi-asserted-by":"publisher","first-page":"e0006914","DOI":"10.1371\/journal.pntd.0006914","volume":"12","author":"T Sunyoto","year":"2018","unstructured":"Sunyoto T, Verdonck K, El Safi S, Potet J, Picado A, Boelaert M. Uncharted territory of the epidemiological burden of cutaneous leishmaniasis in sub-saharan Africa-A systematic review. PLoS Negl Trop Dis. 2018;12(10):e0006914.","journal-title":"PLoS Negl Trop Dis"},{"key":"9518_CR10","doi-asserted-by":"crossref","unstructured":"Libardo J, G\u00f3mez RvW L, van Selm A, Rivera MC, Barbosa WH, van Brakel JA, Quintero W. Mitzi Waltz, and Karl Philipp Puchner. Stigma, participation restriction and mental distress in patients affected by leprosy, cutaneous leishmaniasis and Chagas disease: a pilot study in two co-endemic regions of eastern Colombia. Transactions of the Royal Society of Tropical Medicine and Hygiene. 2019:1\u20137.","DOI":"10.1093\/trstmh\/trz132"},{"key":"9518_CR11","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.eclinm.2018.12.009","volume":"6","author":"S van Henten","year":"2018","unstructured":"van Henten S, Adriaensen W, Fikre H, Akuffo H, Diro E, Hailu A, et al. Cutaneous Leishmaniasis due to Leishmania Aethiopica. EClinicalMedicine. 2018;6:69\u201381.","journal-title":"EClinicalMedicine"},{"key":"9518_CR12","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.15243\/jdmlm.2018.053.1217","volume":"5","author":"M Teshome","year":"2018","unstructured":"Teshome M. Climate variability, communities\u2019 perceptions and land management strategies in Lay Gayint Woreda. Northwest Ethiopia J Degraded Min Lands Manage. 2018;5:1217\u201335.","journal-title":"Northwest Ethiopia J Degraded Min Lands Manage"},{"issue":"3","key":"9518_CR13","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/j.1365-2230.1994.tb01167.x","volume":"19","author":"AY Finlay","year":"1994","unstructured":"Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI)--a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19(3):210\u20136.","journal-title":"Clin Exp Dermatol"},{"issue":"1","key":"9518_CR14","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1186\/s12889-018-5260-9","volume":"18","author":"I Bennis","year":"2018","unstructured":"Bennis I, De Brouwere V, Belrhiti Z, Sahibi H, Boelaert M. Psychosocial burden of localised cutaneous leishmaniasis: a scoping review. BMC Public Health. 2018;18(1):358.","journal-title":"BMC Public Health"},{"issue":"8","key":"9518_CR15","first-page":"474","volume":"16","author":"B Vares","year":"2013","unstructured":"Vares B, Mohseni M, Heshmatkhah A, Farjzadeh S, Safizadeh H, Shamsi-Meymandi S, et al. Quality of life in patients with cutaneous leishmaniasis. Arch Iran Med. 2013;16(8):474\u20137.","journal-title":"Arch Iran Med"},{"issue":"10","key":"9518_CR16","doi-asserted-by":"publisher","first-page":"e0005090","DOI":"10.1371\/journal.pntd.0005090","volume":"10","author":"MK Chahed","year":"2016","unstructured":"Chahed MK, Bellali H, Ben Jemaa S, Bellaj T. Psychological and psychosocial consequences of zoonotic cutaneous leishmaniasis among women in Tunisia: preliminary findings from an exploratory study. PLoS Negl Trop Dis. 2016;10(10):e0005090.","journal-title":"PLoS Negl Trop Dis"},{"issue":"12","key":"9518_CR17","doi-asserted-by":"publisher","first-page":"e0189906","DOI":"10.1371\/journal.pone.0189906","volume":"12","author":"I Bennis","year":"2017","unstructured":"Bennis I, Belaid L, De Brouwere V, Filali H, Sahibi H, Boelaert M. The mosquitoes that destroy your face. Social impact of cutaneous leishmaniasis in South-eastern Morocco, a qualitative study. PLoS ONE. 2017;12(12):e0189906.","journal-title":"PLoS ONE"},{"key":"9518_CR18","unstructured":"Mohammad Ali Nilforoushzadeh HR, Jaffary F, Khatuni M. Comparison of quality of life in women suffering from cutaneous leishmaniasis treated with topical and systemic glucantime along with Psychiatric Consultation compared with the Group without. Psychiatric Consultation Skin Leishmaniasis 2010; 1(1)."}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-024-09518-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-024-09518-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-024-09518-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T17:01:50Z","timestamp":1718730110000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-024-09518-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,18]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["9518"],"URL":"https:\/\/doi.org\/10.1186\/s12879-024-09518-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3996085\/v1","asserted-by":"object"}]},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,18]]},"assertion":[{"value":"28 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was secured from the Research and Ethical Review Committee of the College of Science (RECCS), Bahir Dar University (Ref RCSVD 002). The supportive letter was also obtained from the Amhara Public Health Institute (APHI) (Ref. No. H\/R\/T\/T\/D 03\/1332011), an institute responsible for research conducted in the Amhara Region. Written informed consent was obtained from each study participant in their local language and the study participants were kept anonymous to maintain their medical confidentiality rights: Personal identifier variables like names were not included in the data collection tool.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"598"}}